| |
| |
| Exchange: |
New York Stock Exchange |
| Security
Type: |
Common |
| Shares
Out: |
289,870,000 |
| Market
Cap: |
68.00(B) |
| Last
Volume: |
1,685,938 |
Avg
Vol: |
1,403,311 |
| 52
Week Range: |
$230.48 - $283.59 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Health Services |
| Level
III Sector: |
Medical Instruments & Supplies |
|
Member Indexes:
|
| |
S&P COMPOSITE 1500 |
|
NYSE COMPOSITE |
| |
S&P 500 |
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : 224 |
| Guru Rank Value : 5.4 |
| Guru Occurances : 3 |
|
|
|
|
|
| |
|
Company Profile Becton, Dickinson and Company is a medical technology company engaged in the development, manufacture and sale of a range of medical supplies, devices, laboratory equipment and diagnostic products. Co.'s business segments are: BD Medical, which produces an array of medical technologies and devices that are used to help improve healthcare delivery in a range of settings; BD Life Sciences, which provides products for the safe collection and transport of diagnostics specimens, and instruments and reagent systems to detect a range of infectious diseases, healthcare-associated infections and cancers; and BD Interventional, which provides vascular, urology, oncology and surgical products.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
282 |
3,677 |
9,258 |
39,261 |
| Total Sell Value |
$67,198 |
$869,357 |
$2,420,786 |
$10,261,828 |
| Total People Sold |
1 |
3 |
5 |
7 |
| Total Sell Transactions |
1 |
3 |
7 |
14 |
| End Date |
2024-02-01 |
2023-10-31 |
2023-05-02 |
2022-05-02 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Spoerel Thomas J |
VP Controller & Chief Acct Off |
• – – |
2019-11-26 |
4/A |
A |
$0.00 |
$0 |
D/D |
596 |
1,541 |
|
- |
|
| Lim James C |
Executive Vice President |
• – – |
2019-11-26 |
4 |
A |
$0.00 |
$0 |
D/D |
1,773 |
18,966 |
|
- |
|
| Reidy Christopher R |
CFO and EVP of Administration |
• – – |
2019-11-26 |
4 |
D |
$0.00 |
$0 |
D/D |
(3,747) |
27,210 |
|
- |
|
| Reidy Christopher R |
CFO and EVP of Administration |
• – – |
2019-11-26 |
4 |
A |
$0.00 |
$0 |
D/D |
4,873 |
30,957 |
|
- |
|
| Mas Ribo Alberto |
EVP and Pres, Life Sciences |
• – – |
2019-11-26 |
4 |
D |
$0.00 |
$0 |
D/D |
(1,403) |
15,586 |
|
- |
|
| Mas Ribo Alberto |
EVP and Pres, Life Sciences |
• – – |
2019-11-26 |
4 |
A |
$0.00 |
$0 |
D/D |
1,507 |
16,989 |
|
- |
|
| Polen Thomas E Jr |
Executive Vice President |
• – – |
2019-11-26 |
4 |
D |
$0.00 |
$0 |
D/D |
(3,768) |
17,117 |
|
- |
|
| Polen Thomas E Jr |
Executive Vice President |
• – – |
2019-11-26 |
4 |
A |
$0.00 |
$0 |
D/D |
4,430 |
20,885 |
|
- |
|
| Forlenza Vincent A |
Chairman, CEO and President |
• • – |
2019-11-26 |
4 |
D |
$0.00 |
$0 |
D/D |
(13,190) |
209,050 |
|
- |
|
| Forlenza Vincent A |
Chairman, CEO and President |
• • – |
2019-11-26 |
4 |
A |
$0.00 |
$0 |
D/D |
16,742 |
222,240 |
|
- |
|
| Spoerel Thomas J |
VP Controller & Chief Acct Off |
• – – |
2019-11-26 |
4 |
A |
$0.00 |
$0 |
D/D |
620 |
1,130 |
|
- |
|
| Spoerel Thomas J |
VP Controller & Chief Acct Off |
• – – |
2019-11-26 |
4 |
D |
$0.00 |
$0 |
D/D |
(248) |
945 |
|
- |
|
| Forlenza Vincent A |
Chairman, CEO and President |
• • – |
2019-10-21 |
4 |
GD |
$0.00 |
$0 |
D/D |
15,590 |
205,498 |
|
- |
|
| Spoerel Thomas J |
VP Controller & Chief Acct Off |
• – – |
2019-10-01 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
52 |
|
- |
|
| Spoerel Thomas J |
VP Controller & Chief Acct Off |
• – – |
2019-10-01 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
758 |
|
- |
|
| Forlenza Vincent A |
Chairman, CEO and President |
• • – |
2019-09-06 |
4 |
AS |
$260.38 |
$3,002,702 |
D/D |
(11,532) |
221,088 |
|
- |
|
| Forlenza Vincent A |
Chairman, CEO and President |
• • – |
2019-09-06 |
4 |
D |
$260.38 |
$1,252,688 |
D/D |
(4,811) |
232,620 |
|
- |
|
| Forlenza Vincent A |
Chairman, CEO and President |
• • – |
2019-09-06 |
4 |
OE |
$76.64 |
$1,252,528 |
D/D |
16,343 |
237,431 |
|
- |
|
| Lim James C |
Executive Vice President |
• – – |
2019-09-06 |
4 |
S |
$263.53 |
$2,450,565 |
D/D |
(9,299) |
17,193 |
|
- |
|
| Lim James C |
Executive Vice President |
• – – |
2019-09-06 |
4 |
D |
$263.53 |
$1,725,858 |
D/D |
(6,549) |
26,492 |
|
- |
|
| Lim James C |
Executive Vice President |
• – – |
2019-09-06 |
4 |
OE |
$108.89 |
$1,725,689 |
D/D |
15,848 |
33,041 |
|
- |
|
| Polen Thomas E Jr |
Executive Vice President |
• – – |
2019-09-06 |
4 |
AS |
$260.26 |
$1,515,494 |
D/D |
(5,823) |
16,455 |
|
- |
|
| Polen Thomas E Jr |
Executive Vice President |
• – – |
2019-09-06 |
4 |
D |
$260.26 |
$2,065,684 |
D/D |
(7,937) |
22,778 |
|
- |
|
| Polen Thomas E Jr |
Executive Vice President |
• – – |
2019-09-06 |
4 |
OE |
$150.12 |
$2,065,651 |
D/D |
13,760 |
30,215 |
|
- |
|
| Bodner Charles R |
SVP Corp Fin Chief Acct Office |
• – – |
2019-09-06 |
4 |
AS |
$260.08 |
$393,761 |
D/D |
(1,514) |
2,037 |
|
- |
|
1851 Records found
|
|
Page 14 of 75 |
|
|
1.16 (0.5%) 
